SIHUAN PHARMAC.GRP HD-,01 financial statements, including revenue, expenses, profit, and loss
The total revenue of TEL1 for the last semiannual is 100.86 M EUR, and it's 27.77% lower compared to the previous semiannual. The net income of H2 23 is -548.00 k EUR.